MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro

Renal fibrosis is a common pathological feature of various kidney diseases, leading to irreversible renal failure and end-stage renal disease. However, there are still no effective treatments to reverse renal fibrosis. This study aimed to explore the potential mechanism of a targeted drug for fibros...

Full description

Bibliographic Details

Main Authors:	Meiling Chen, Yihang Yu, Tao Mi, Qitong Guo, Bin Xiang, Xiaomao Tian, Liming Jin, Chunlan Long, Lianju Shen, Xing Liu, Jianbo Pan, Yuanyuan Zhang, Tao Xu, Deying Zhang, Guanghui Wei
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2022-11-01
Series:	Cells
Subjects:	chronic kidney diseases renal fibrosis MK-2206 Akt/mTOR signaling pathway
Online Access:	https://www.mdpi.com/2073-4409/11/21/3505
Tags:	Add Tag No Tags, Be the first to tag this record!